Protective role of DNA vaccination and passive immunization against the 1918 pandemic influenza virus

被引:0
作者
Wong, Jonathan P. [1 ]
机构
[1] Def R&D Canada Suffield, Chem & Biol Def Sect, Mol Biol Grp, Medicine Hat, AB T1A 8K6, Canada
关键词
1918 influenza virus; DNA vaccination; pandemic; passive immunity; protection;
D O I
10.2217/17460913.2.2.107
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Lessons learnt from the 1918 Spanish influenza pandemic indicate that the world is vulnerable to pandemic viruses and that effective medical countermeasures are urgently needed to protect against future pandemics. The work, as published by Kong and colleagues, involved the use of genetically reconstructed 1918 pandemic virus and is of significant importance for a number of reasons. First, it highlights how advanced technology such as DNA vaccination could provide a modern solution for protection against a historic killer virus, such as the 1918 Spanish flu virus, and second, this paper describes the elucidation of the protective immunity that contributes to neutralization of virus infectivity, and therefore provides insights on the role of humoral and cellular responses in contributing to protective immunity against this virus. Third, it highlights the effectiveness of passive immunization using neutralizing antibody to protect against lethal virus challenge. The scientific information provided in this study is of significant importance in increasing our understanding of the infectivity and immunity of pandemic virus, and may better enhance our ability to prevent and treat future influenza infection caused by pandemic viruses.
引用
收藏
页码:107 / 110
页数:4
相关论文
共 9 条
[1]   DNA vaccines: Progress and challenges [J].
Donnelly, JJ ;
Wahren, B ;
Liu, MA .
JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :633-639
[2]   Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice [J].
Hanson, Brendon J. ;
Boon, Adrianus C. M. ;
Lim, Angeline P. C. ;
Webb, Ashley ;
Ooi, Eng Eong ;
Webby, Richard J. .
RESPIRATORY RESEARCH, 2006, 7 (1)
[3]   Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic [J].
Johnson, NPAS ;
Mueller, J .
BULLETIN OF THE HISTORY OF MEDICINE, 2002, 76 (01) :105-115
[4]   Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination [J].
Kong, Wing-pui ;
Hood, Chantelle ;
Yang, Zhi-yong ;
Wei, Chih-Jen ;
Xu, Ling ;
Garcia-Sastre, Adolfo ;
Tumpey, Terrence M. ;
Nabel, Gary J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (43) :15987-15991
[5]   Human clinical trials of plasmid DNA vaccines [J].
Liu, Margaret A. ;
Ulmer, Jeffrey B. .
ADVANCES IN GENETICS, 2005, 55 :25-40
[6]   Cell-mediated protection in influenza infection [J].
Thomas, PG ;
Keating, R ;
Hulse-Post, DJ ;
Doherty, PC .
EMERGING INFECTIOUS DISEASES, 2006, 12 (01) :48-54
[7]   Characterization of the reconstructed 1918 Spanish influenza pandemic virus [J].
Tumpey, TM ;
Basler, CF ;
Aguilar, PV ;
Zeng, H ;
Solórzano, A ;
Swayne, DE ;
Cox, NJ ;
Katz, JM ;
Taubenberger, JK ;
Palese, P ;
García-Sastre, A .
SCIENCE, 2005, 310 (5745) :77-80
[8]  
van Aken J, 2007, HEREDITY, V98, P1, DOI 10.1038/sj.hdy.6800911
[9]  
*VIC CO INF, 2006, SINGL INJ VIC AV FLU